BioAsia 2024: 3,000 delegates from 50 countries to join Asia’s biggest healthcare event in Hyderabad

Hyderabad: BioAsia - the healthcare and Life Sciences event, organized by the Telangana government, is scheduled to be held between February 26 and 28, 2024 at the Hyderabad International Convention Centre (HICC) in Hyderabad.

Duddilla Sridhar Babu, Minister for Information Technology, Industries & Commerce, Telangana, held a comprehensive review of the preparations for the upcoming global conference on Thursday.

Global leaders to partake in the 3-day forum

The 21st edition of BioAsia will feature prominent government dignitaries, industry leaders, scientists, academia, regulatory body representatives, entrepreneurs, and other delegates and will explore the theme of Data & AI: Redefining Possibilities, to deliberate the possibility of reshaping the future of health tech delivery paradigm in the country.

Influential speakers to attend

The event will have a lineup of around 70 influential speakers, including global CEOs and industry leaders. The keynote speakers include David Ricks (CEO, Eli Lilly and Company), Dr Christopher Boerner (Incoming CEO, Bristol Myers Squibb), Geoff Martha (Chairman and CEO, Medtronic), Prof. Gregg Semenza (Nobel Laureate and Professor at Johns Hopkins School of Medicine), among others. The event will also feature President and CEO of Olympus Stefan Kaufmann, CEO of Providence Dr. Rod Hochman, MD, Global Operating Partner of Advent International Stefan Stoffel, among others.

200 plus companies will showcase their products

BioAsia 2024 is projected to attract over 3000 participants, offering a dynamic platform for networking and collaboration. Further, the event will have an increased exhibition this year with more than 200 companies set to showcase some of the most groundbreaking advancements and cutting-edge products. As the city welcomes numerous globally influential leaders, the event will provide a fertile ground for knowledge exchange and innovation in the life sciences and biotechnology sector. BioAsia 2024 will also offer a worldwide platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to showcase their inventive concepts.

Efforts to make the event impactful

Minister Sridhar Babu, said, "BioAsia has emerged as a critical instrument for the development of the Indian and global Life-Sciences and allied industries over the last two decades. Several global CEOs will be attending BioAsia for the first time, underlining the event's rising prominence on the international stage. My team and I are leaving no stone unturned to ensure that BioAsia 2024 is grand and impactful."

Jayesh Ranjan, Principal Secretary, Industries and Commerce Department, said, "Over the past 20 editions, BioAsia has played an unmatched role in sparking the renewed emphasis on the life-sciences industry, rekindling attention from regulation, corporates, startups, and allied sectors alike."

"The 21st edition of BioAsia is certainly going to be a milestone event, as the presence of global leaders marks the vision to bridge the gaps in the healthcare industry and foster innovation in these critical sectors,” said Shakthi Nagappan, Director of Life Sciences, Government of Telangana and CEO of BioAsia.

Pertinent themes on focus:

The event, with EY as the knowledge partner, will focus on themes including Transformative innovation – R&D; Patent Paradox: India's Bid for Global R&D Dominance & IP Dilemmas; Leading the Health-tech Revolution - The Next Normal; India at the frontier of Pharma Services, MedTech, etc.

As the Flagship event of the Telangana government, BioAsia has emerged as a pivotal player in steering the life-sciences development journey in India, playing a crucial role in redirecting focus towards the advancements and challenges within the industry.